On November 15, 2022, Davis Polk partner James Lin will be among the speakers at BioCentury and BayHelix’s East-West BioPharma Summit. James will chair the “3rd Annual Davis Polk C-Suite Bootcamp: Developing Routes to Global Capital” workshop. Topics discussed will include dual-listing approaches to help tap liquidity across markets, how executives should prepare for the next favorable financing window, and how Asian companies can comply with evolving auditing requirements and avoid de-listing risks.

For more information, please visit the event website.